Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Syros Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SYRS is no longer listed, and 13F filings after Q4 2024 list far fewer holders. See Q4 2024
- Institutional holders
- 7
- −37 vs. Q4 2024
- Shares held
- 483.2K
- −4.75M (−90.8%) vs. Q4 2024
- Total value
- $12.4K
- −$1.19M (−99.0%) vs. Q4 2024
- New holders
- 1
- 3 more added
- Sold out
- 38
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SYRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $12.4K |
| Q4 2024 | 44 | $1.20M |
| Q3 2024 | 65 | $40.8M |
| Q2 2024 | 70 | $105.2M |
| Q1 2024 | 75 | $111.9M |
| Q4 2023 | 58 | $146.8M |
| Q3 2023 | 48 | $47.9M |
| Q2 2023 | 53 | $33.5M |
| Q1 2023 | 59 | $27.5M |
| Q4 2022 | 57 | $37.9M |
| Q3 2022 | 53 | $59.9M |
| Q2 2022 | 69 | $34.2M |
| Q1 2022 | 94 | $53.1M |
| Q4 2021 | 90 | $166.0M |
| Q3 2021 | 100 | $223.1M |
| Q2 2021 | 100 | $276.0M |
| Q1 2021 | 106 | $475.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Syros Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 329,793 | $9.00K | 0.00% | +80,367+32.2% | Added |
| Baader Bank INC | 83,864 | $1.91K | 0.00% | +61,772+279.6% | Added |
| 1492 Capital Management LLC | 39,244 | $1.18K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 10,053 | $290 | 0.00% | −71,407−87.7% | Reduced |
| FNY Investment Advisers, LLC | 16,100 | $0 | 0.00% | +11,000+215.7% | Added |
| Steward Partners Investment Advisory, LLC | 8 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 4,123 | $0 | 0.00% | +4,123 | New |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −2,750,151−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −277,253−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −268,154−100.0% | Sold out |
| Omega Fund Management, LLC | 0 | $0 | 0.00% | −251,270−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −196,252−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −139,224−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −122,174−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −107,742−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −96,042−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −87,535−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −69,430−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −52,920−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −48,861−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −45,050−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −40,812−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −32,791−100.0% | Sold out |
| Clarius Group, LLC | 0 | $0 | 0.00% | −18,620−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −14,898−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −9,970−100.0% | Sold out |
| Centerpoint Advisors, LLC | 0 | $0 | 0.00% | −10,659−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,629−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,355−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −1,883−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,684−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,095−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −549−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −454−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −212−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Activest Wealth Management | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| PSI Advisors, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |